Inventor
MATHIS JR CHESTER A
US20 patents
⚠️ This page may combine multiple inventors who share the name “MATHIS JR CHESTER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV PITTSBURGH
10 patentsUS6168776B1Jan 2, 2001
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
UNIV PITTSBURGH120 citations98
US6417178B1Jul 9, 2002
Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
UNIV PITTSBURGH148 citations97
US7270800B2Sep 18, 2007
Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
UNIV PITTSBURGH50 citations96
US6133259AOct 17, 2000
Alkyl, alkenyl and alkynyl chrysamine G derivatives for inhibition of cell degeneration and toxicity associated with amyloid deposition
UNIV PITTSBURGH42 citations95
US6114175ASep 5, 2000
Compound for the antemortem diagnosis of Alzheimer's Disease and in vivo imaging and prevention of amyloid deposition
UNIV PITTSBURGH72 citations95
US7854920B2Dec 21, 2010
Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
UNIV PITTSBURGH14 citations92
US7351401B2Apr 1, 2008
Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition
UNIV PITTSBURGH28 citations92
US8911707B2Dec 16, 2014
Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
UNIV PITTSBURGH5 citations84
US8580229B2Nov 12, 2013
Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
UNIV PITTSBURGH7 citations84
US8343457B2Jan 1, 2013
Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
UNIV PITTSBURGH7 citations84
KLUNK WILLIAM E
5 patentsUS8404213B2Mar 26, 2013
Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
KLUNK WILLIAM E11 citations92
US8236282B2Aug 7, 2012
Benzothiazole derivative compounds, compositions and uses
KLUNK WILLIAM E13 citations92
US8691185B2Apr 8, 2014
Benzothiazole derivative compounds, compositions and uses
KLUNK WILLIAM E7 citations83
US8147798B2Apr 3, 2012
Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
KLUNK WILLIAM E11 citations83
US8138360B2Mar 20, 2012
Isotopically-labeled benzofuran compounds as imaging agents for amyloidogenic proteins
KLUNK WILLIAM E6 citations72
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
3 patentsUS9808541B2Nov 7, 2017
Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION1 citations62
US10137210B2Nov 27, 2018
Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations52
US9833458B2Dec 5, 2017
Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations52